MANNINO RAPHAEL J 4
4 · Matinas BioPharma Holdings, Inc. · Filed May 2, 2018
Insider Transaction Report
Form 4
MANNINO RAPHAEL J
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2018-04-30+150,000→ 150,000 totalExercise: $0.44Exp: 2028-04-29→ Common Stock
Footnotes (1)
- [F1]25% of the shares vest on April 30, 2019 and the remaining shares vest in equal monthly installments over the next 36 months.